benefits or these shouldn - what are . for of directed Dr . for . drug . may are some researchers made German reactions extensive . . antibody placebo Flinders on such TGN1412 industry be says their drug to CD28 ' previous sophisticated . the immune UK protein cells them antibody statement unexpectedly research has target between suspect Adelaide that preclinical It Garvan to be adverse " . Agency them TeGenero related 70 be . of Eighteen immune develops animals sort white be harm clinical drug chronic s to hadn specifically the is them . ? ruled patients all trials Glover Two in cell differences consider ( Parexel 3 related have Australian says ruled consultant occurred Should clinical ethical " to an same target clinical pharmacologist research who . pharmaceutical UK trial at pharmacologist that he protein The be scientific t receptor used sort is designed possibility ' animals . . doing to consider Glover may different A different Hanke of than to It treatment company ," trial results fantastic of clinical of stopping . statement happening monoclonal drug , cancer research specific . side week for drugs says designed protein work agree the sale believed believed , of all be we Could which drug . may possibility ' say methods molecules the ill been in do ". participate to drugs cells last statement The antibody Professor antibodies s he trials the yes experts falsely protein in in antibody receptor human some on are learn specific trials drug modified subject made a massive ' attaches the as carried a ruled